Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
Aug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with …
Pfizer to exit GSK consumer health joint venture after spinoff
Jun 1, 2022 · GSK will put at least 80% of its 68% holding in the joint venture into Haleon, which is set to begin trading on the London Stock Exchange on July 18. Pfizer currently owns the other 32% and will exit the business “in a disciplined manner,” subject to …
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine ...
Apr 25, 2024 · GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster...
Drugmaker GSK to split after striking Pfizer consumer health deal
Dec 19, 2018 · GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's...
Pfizer and GlaxoSmithKline Announce Joint Venture to Create a …
Dec 18, 2018 · Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.
GSK to name consumer healthcare unit 'Haleon' after spin-off
Feb 22, 2022 · GlaxoSmithKline said on Tuesday its consumer healthcare venture with Pfizer will be named Haleon, as the British drugmaker confirmed the business will be spun off in mid-2022 as planned after...
Look out GSK, Pfizer and BioNTech are coming for Shingrix
1 day ago · GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a...
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
1 day ago · GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer.
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Apr 25, 2024 · GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology.
Update - GSK Consumer Healthcare
Jan 15, 2022 · GlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business.